MONOLISA Anti-HAV IgM EIA

MONOLISA Anti-HAV IgM EIA is for the detection of IgM antibodies to hepatitis A virus (HAV) in human (adult or pediatric) serum or plasma. Specific IgM antibodies to HAV (anti-HAV IgM) appear a few days after infection, reach a peak rapidly, and persist at elevated levels in the bloodstream for about two months, before declining during late convalescence. The recent availability of anti-HAV vaccines has prompted the development of more sensitive assays, used for screening unvaccinated individuals, to follow up on antibody response after vaccination, and to estimate the need and timing of booster vaccinations. Specificity in hepatitis testing is critical—trust Bio-Rad’s expertise in immunology and continually updated reagents for all hepatitis testing needs.